CDKN1B and amyotrophic lateral sclerosis: From what has been discussed above, we clarify the importance of Cdkn1b (P27) and Eif4ebp1, as biomarkers for more comprehensively understanding and identifying the pathogenesis of ALS responding to ET-1 intervention.